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RelB activation in anti-
inflammatory decidual endothelial 
cells: a master plan to avoid 
pregnancy failure?
Elisa Masat1,*, Chiara Gasparini2,*, Chiara Agostinis2, Fleur Bossi1, Oriano Radillo2, 
Francesco De Seta1,2, Nicola Tamassia3, Marco A. Cassatella3 & Roberta Bulla1
It is known that excessive inflammation at fetal-maternal interface is a key contributor in a 
compromised pregnancy. Female genital tract is constantly in contact with microorganisms and 
several strategies must be adopted to avoid pregnancy failure. Decidual endothelial cells (DECs) 
lining decidual microvascular vessels are the first cells that interact with pro-inflammatory stimuli 
released into the environment by microorganisms derived from gestational tissues or systemic 
circulation. Here, we show that DECs are hypo-responsive to LPS stimulation in terms of IL-6, 
CXCL8 and CCL2 production. Our results demonstrate that DECs express low levels of TLR4 and are 
characterized by a strong constitutive activation of the non-canonical NF-κB pathway and a low 
responsiveness of the canonical pathway to LPS. In conclusion, DECs show a unique hypo-responsive 
phenotype to the pro-inflammatory stimulus LPS in order to control the inflammatory response at 
feto-maternal interface.
Human endothelial cells (ECs) are multifunctional cells that line blood vessels, capable to secrete a vari-
ety of biologically active mediators. In disease states, ECs are activated by several mechanisms enhanc-
ing the expression of cell adhesion molecules and cytokines, in order to orchestrate the inflammatory 
response1. ECs, although similar in function and morphology, represent an heterogeneous population of 
cells in terms of secretion of inflammatory mediators, modulation of adhesion molecules, leakiness and 
pro-coagulant activity2. LPS is a strong activator of ECs3, and is recognized by a multi-receptor complex 
composed by TLR4 and myeloid differentiation-2 (MD2)4 through the involvement of LPS-binding protein 
(LBP) and CD14. TLR4 transduces its signal through two main pathways: the MyD88-dependent path-
way, which mediates the early NF-κ B activation, and the MyD88-independent pathway (TRIF-dependent 
pathway), which mediates the delayed NF-κ B activation5.
The NF-κ B family is composed of 5 subunits, p65, p50, RelB, p52 and c-rel, that act as homo- and 
hetero-dimers, with the exception of RelB, which is found in its active form only as RelB/p50 or RelB/
p52 hetero-dimers. The canonical NF-κ B pathway is mediated by the dimer p65/p50, has an early activa-
tion kinetic and is involved in pro-inflammatory responses, cell survival and innate immunity. A second 
pathway, that relies on RelB/p50 and RelB/p52, has been characterized with a delayed activation kinetic6. 
It modulates the secondary lymphoid organ development, acquired immunity7 and, very interestingly, 
downregulates inflammation8.
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Excessive inflammation at fetal-maternal interface is thought to be a key contributor in a compro-
mised pregnancy. Intrauterine infections have been associated with pregnancy complications such as 
preterm labor, intrauterine growth restriction and pre-eclampsia9. Due to their location and properties, 
the microvascular ECs that line decidual vessels are very likely to play an important role in the control 
of the inflammatory response at feto-maternal interface.
In this study we investigated how decidual endothelial cells respond to LPS in terms of cytokine 
production, expression of TLR4 and signal transduction.
Results and Discussion
Production of pro-inflammatory cytokines by endothelial cells. We compared the production 
of the pro-inflammatory cytokines IL-6, CXCL8 (IL-8) and CCL2 (MCP-1) upon stimulation with TNF-
α or LPS in DECs, ADMECs, UtMECs and HUVECs. As expected10, HUVECs promptly respond to 
TNF-α or LPS producing IL-6, CXCL8 and CCL2 (Fig. 1). Similar results were obtained in ADMECs, 
and UtMECs. Interestingly, a very low production of these cytokines was observed when DECs were 
stimulated by LPS. DECs’ low responsiveness does not seem to be time or dose dependent as assessed 
by time course and dose-response experiments on DECs and ADMECs (Fig.  1B). We were not sur-
prised about this atypical behaviour of DECs upon LPS challenge, since we previously observed that LPS 
enhances the expression of inflammasome components and induce IL-1β secretion in trophoblasts and 
in decidual stromal cells but not in DEC11.
DECs have a lower TLR4 expression and a constitutive activation of the NF-κB non- canonical 
pathway. The results in Fig.  2A show that DECs express lower TLR4 mRNA levels than ADMECs. 
The flow cytometric analysis in Fig.  2B confirmed the RT-qPCR data, showing that TLR4 is present 
on EC surface, even though its expression on DECs is very weak compared to the high expression on 
ADMECs. RT-qPCR experiments, summarized in Supplemental Fig.  1, show that both population of 
ECs, unlike macrophages used as a positive control, do not express the mRNA for CD14; interestingly 
DECs have also a trend to a reduced expression of the MD2, MyD88 and TRIF mRNA. These data are 
in agreement with Wang and colleagues who observed a significant downregulation of MyD88 and TRIF 
in the LPS tolerant glial cells12.
Since LPS induces a weak pro-inflammatory response in DECs, we aimed to investigate the acti-
vation of the NF-κ B pathways, that play a central role in modulating both pro-inflammatory and 
anti-inflammatory conditions13. The activation of the subunits p65 and p50 (canonical pathway) and of 
the subunits RelB, p50 and p52 (non-canonical pathway) was measured over a time-course (Fig.  2C). 
The p65 subunit is strongly activated by LPS in ADMECs from 45 min to 24 h. In DECs, p65 shows a 
certain basal activation and is mildly activated at 45 min stimulation with LPS, but not at later time points 
(Fig. 2C). It is evident that the canonical pathway has not a major role in DECs functions, as compared 
to the LPS-responsive cells.
The subunit RelB shows a retarded activation, as expected6. Upon LPS stimulation both cell types are 
characterized by a strong activation of RelB. Very interestingly, RelB shows a high basal activation in 
DECs which is not observed in ADMECs (Fig. 2C) and, more importantly, such basal activation is not far 
from its full LPS-dependent activation. In both cell types, p52 is not activated in response to LPS while 
p50 shows a strong basal activation, that clearly increases after LPS stimulation.
RelB basal activation and p65 low responsiveness to LPS activation seem to be the most relevant 
features of DECs. A similar basal activation has been observed in cancer14 or in endotoxin tolerance. In 
endotoxin tolerance, RelB has a key role in silencing or inhibiting the expression of the pro-inflammatory 
cytokines TNF-α and IL-1β 15 and, when overexpressed, the dimer RelB/p50 inhibits the production of 
TNF-α in primary dendritic cells and macrophages8. Together with RelB activation, unstimulated DECs 
showed a reduced expression of Iκ Bα (Fig. 2C), the physiological inhibitor of the canonical pathway, that 
only slightly diminishes after LPS stimulation. This evidence would sustain the observed basal activation 
of p65 and its low responsiveness to LPS. In ADMECs, Iκ Bα expression is high in unstimulated cells, 
and rapidly decreases upon LPS activation, as occurring in LPS-responsive cells where the canonical 
pathway has a major role. Recently, miR-146 has been reported to regulate RelB expression in TNF-α 
stimulated cells16 and to repress endothelial activation17. We verified that miR-146 is highly expressed in 
untreated DECs as compared to ADMECs (Fig. 2D) and therefore could have a role in regulating RelB 
activity in these cells.
To conclude, DECs are characterized by a strong constitutive activation of the NF-κB non-canonical 
pathway and a low responsiveness to LPS. Our finding shows a snapshot of a very atypical endothelium 
that, in order to avoid pregnancy failure, increases the activation threshold to LPS. This is in harmony 
with the concept of immune tolerance to microorganism during pregnancy18.
Materials and Methods
Tissues samples. Decidual first trimester biopsy specimens were obtained from women undergoing 
voluntary termination of pregnancy at 8–12 weeks’ gestation. Skin samples were obtained from women of 
fertile age undergoing reductive plastic surgery. Endometrial tissue specimens were obtained from fertile 
women undergoing hysterectomy for leiomyomatosis in the mid proliferative and mid secretory phase 
defined according to Noyes criteria19. The study was approved by the institutional review board of The 
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Figure 1. Cytokine and chemokine production by ECs after stimulation with inflammatory stimuli. 
(A) The box plots represent the production of IL-6, CXCL8 (IL-8) and CCL2 (MCP-1) in the supernatants 
of confluent monolayers of HUVECs, ADMECs, UtMEC and DECs. All the ECs examined produced high 
level of cytokines and chemokines in response to TNF-α and LPS excepted DECs which produced low 
levels of these pro-inflammatory cytokines. Box plot ± S.D. of at least 5 independent experiments. *P < 0.05 
and **P < 0.01 untreated versus treated (Mann-Whitney test). (B) Dose response curve of LPS effect on 
DECs and ADMECs in the cytokines production. The cells were stimulated with increasing concentrations 
of LPS (0 ng/ml, 10 ng/ml, 100 ng/ml, 500 ng/ml and 1000 ng/ml) and the cells supernatants were analyzed 
for the presence of of IL-6, CXCL8 (IL-8) and CCL2 (MCP-1). If compared to ADMECs, DECs are poorly 
respondent to LPS stimulation and at 100 ng/ml of LPS DECs reach the maximum of cellular activation. 
(C) Time course of LPS effect on ECs in the cytokines production. The cells were stimulated for 4 h, 12 h 
or 24 h with LPS and the cells supernatants were analyzed for cytokine production. The maximum amount 
of cytokines produced by DECs was at 12 h. Data from three independent experiments are shown and 
represent the mean ± SD. *P < 0.05 (Mann-Whitney test) ADMECs versus DECs.
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Figure 2. Expression of TLR4, NF-kB pathways and miRNA in ECs. (A) Analysis of RT-qPCR for the 
expression of TLR4 mRNA in EC populations. The relative amount of mRNA for TLR4 in DECs, ADMECs, 
HEK 293T and THP-1 was evaluated by RT-qPCR and normalized with reference to the 18S value. The 
results were expressed as AUs, in which 1 AU represents the value obtained with macrophages (PBMC) used 
as a calibrator. Bars represent the mean ± S.E.M. of at least 3 independent experiments. *P < 0.05 (Mann-
Whitney test) ADMECs versus DECs. (B) Cytofluorimetric analysis for TLR4 surface expression on freshly 
isolated ECs (ADMECs and DECs). DECs present a lower expression of TLR4 both at gene and protein level. 
THP-1 were used as positive control and HEK 293T were used as negative control for TLR4 expression. (C) 
Activation of the signal transduction pathway in ECs. DECs and ADMECs were treated with LPS during a 
time course of 45 min, 4 h, 7 h and 24 h. Cells were then lysed and nuclear extracts assayed with the TransAm 
NF-κ B family kit (Active Motive) to measure the binding of the subunits RelB, p65, p52 and p50 to their 
consensus sequence. Data are shown as mean ± SEM of two independent experiments. Statistical analysis were 
carried out according to Material and Methods. *P < 0.05; **P < 0.01, ***P < 0.001 were calculated versus the 
unstimulated control of the same cell type, except when the conditions analyzed are clearly connected by a 
straight line (comparison of the unstimulated conditions between the two different cell types). In the bottom 
a western blot of DECs and ADMECs lysates is reported to evaluate IkBα degradation, which is indicative of 
the activation of the NFkB canonical pathway. (D) Evaluation of the expression of miR-146 where the relative 
amount of miR-146 in untreated DECs and ADMECs was evaluated by RT-qPCR. Untreated DECs displayed 
6-fold increase the level of miR-146. Bars represent the mean ± S.E.M. of at least 3 independent experiments. 
*P < 0.05 (Mann-Whitney test) ADMECs versus DECs.
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Maternal-Children’s Hospital (IRCCS “Burlo Garofolo”, Trieste, Italy) and informed consent was obtained 
from all patients providing the tissue specimens. All the experiments were carried out in accordance with 
the approved guidelines.
Cell isolation and culture. Human umbilical vein endothelial cells (HUVECs) were isolated by 
collagenase treatment and cultured as previously published20. Decidual endothelial cells (DECs) and 
Human dermal microvascular endothelial cells (ADMECs) were isolated and characterized as previously 
described by Bulla et al.21.
DECs were positively selected with Dynabeads M-450 (Life Technologies) coated with Ulex europaeus 
1 lectin (Sigma–Aldrich), whereas ADMECs were further purified from a subconfluent mixed cell popu-
lation with the CD31-conjugated magnetic beads from Dynabeads (Life Technologies).
Uterine microvascular endothelial cells (UtMECs) were purified from endometrial tissue samples by 
a similar procedure for DECs isolation. Briefly, the tissue was finely minced, digested first with 0.25% 
trypsin (Sigma-Aldrich, Milan, Italy) and 50 μ g/ml DNase I (Roche, Milano, Italy) overnight at 4 °C, 
and then with collagenase type 1 (3 mg/ml) (Worthington Biochemical Corporation, DBA, Milan, Italy) 
for 30 min at 37 °C. After the filtration through a 100 μ m pore nylon filter (BD Falcon, Milan, Italy) the 
cells were positively selected with Dynabeads M-450 (Dynal, Invitrogen, Milano, Italy) coated with Ulex 
europaeus 1 lectin (Sigma-Aldrich).
All ECs were seeded on 12,5 cm2 flask precoated with 2 μ g/cm2 fibronectin (Roche, Milan, Italy) and 
maintained in endothelial serum free basal medium (Life Technologies, Monza, Italy) supplemented 
with 20 ng/ml bFGF (basic Fibroblast Growth Factor), 10 ng/ml EGF (Epidermal Growth Factor) (Life 
Technologies) 10% of FCS (Life Technologies) and 10% of human serum (Euroclone, Milan, Italy).
ELISA. The level of IL-6, CXCL8 (IL-8) and CCL2 (MCP-1) were measured by ELISA using a com-
mercial kit (Human IL-6 Instant ELISA, Bender Medsystem, Milan, Italy; Human IL-8 Instant ELISA, 
Bender Medsystem, Milan, Italy; Human MCP-1 Instant ELISA, Bender Medsystem, Milan, Italy). Each 
assay was performed according to the manufacturer instructions.
RNA extraction, cDNA synthesis and Real-time quantitative PCR (RT-qPCR). Cells RNA were 
purified with euroGOLD Total RNA Kit (Euroclone, Milan, Italy) according to the supplier’s instruc-
tions. miRNA isolation were carried out with miRNeasy Mini Kit (Qiagen, Milan, Italy) according to 
the supplier’s instructions. Total RNA extracted was reverse transcripted with iScript cDNA Synthesis 
Kit (Bio-Rad, Milan, Italy). Real-time quantitative PCR (qPCR) was carried out on a Rotor-Gene 6000 
(Corbett, Explera, Ancona, Italy) using iQ SYBR Green Supermix (Thermo Scientific Fynnzymes, Milan, 
Italy). Table  1 show the primer lists used for qPCR. The relative amount of gene production in each 
sample was determined by the Comparative Quantification (CQ) method supplied as part of the Rotor 
Gene 1.7 software (Corbett Research)22.
Cytofluorimetric Analysis. ECs, HEK 293T and THP-1 (5 × 105 cells) were incubated with the 
(HTA125) monoclonal PE-conjugated anti-human TLR4 antibody (Biolegend, Milan, Italy), with mon-
oclonal FITC-conjugated anti-human MD2 antibody (Hycult Biotech, Milan, Italy), or with unrelated 







18S Forward ATCCCTGAAAAGTTCCAGCA 60 154 NM 022551
Reverse CCCTCTTGGTGAGGTCAATG
TLR4 Forward AAGCCGAAAGGTGATTGTTG 60 153 NM_138557.1
Reverse CTGAGCAGGGTCTTCTCCAC
MD2 Forward TTCCACCCTGTTTTCTTCCATA 60 404 AB446498.1
Reverse GGCTCCCAGAAATAGCTTCAAC
CD14 Forward AGAGGCAGCCGAAGAGTTCAC 60 132 NM_000591.3
Reverse GCGCTCCATGGTCGATAAGT
MyD88 Forward CTCTGTTCTTGAACGTGCGGA 60 246 NM_002468
Reverse ACTTTTGGCAATCCTCCTCAATG
TRIF Forward TGCACTGCGTTCTCATAGTCT 61 167 U49441
Reverse ACTGTGCCATAGGGTCTGATG
hsa miR-146 Forward CGGCTGAATTGGAAATGATA 60 22 MI0000477
Reverse TGCTGCCTCTCAAACAGAAG
Table 1.  Primer used for RT-qPCR analysis.
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antibody for 1 h at 37 °C. The cells were fixed with 1% paraformaldehyde (Sigma-Aldrich) and analyzed 
for fluorescence on a FACScalibur instrument (BD Falcon) using CellQuest software.
Immunoblot. After stimulation, ECs were lysed in lysis buffer (25 mM Tris pH 7.5, NaCl 150 mM, 
Triton X-100 1%, Sodium Deoxycholate 1%, SDS 0,1%, 2 mM EDTA, 1% (v/v) Nonidet P-40, and 1mM 
DTT) containing inhibitors of proteases (Sigma-Aldrich), and phosphatases (Sigma-Aldrich), and fol-
lowing a 15-min incubation on ice, cell debris were spun down (12,000 × g, 20 min, 4 °C) and the super-
natants were frozen and stored at − 80 °C. Small aliquots of the various extracts were routinely processed 
for protein content determination, by using a protein assay kit (Bio-Rad, Milan,Italy). For Western blot 
analysis, cell extracts were subjected to immunoblots by described procedures23. Detection was carried 
out with Alexa FluorR 680-conjugated goat anti-rabbit Abs (Invitrogen) and IRDye™ 800-conjugated 
goat anti-mouse IgG (Rockland, Gilbertsville, PA, USA) secondary Abs. Blotted proteins were detected 
and quantified using the Odyssey infrared imaging system (LI-COR Biosciences, Lincoln, NE, USA). 
Anti-Iκ Ba (sc-371) was obtained from Santa Cruz Biotechnology while anti-β-tubulin (T5293) was from 
Sigma-Aldrich.
DNA binding. DNA binding assay was performed as previously shown24. p65, RelB, p52, p50, bind-
ing to consensus sequence was assayed in nuclear lysates using the TransAm NF-κ B family kit (Active 
Motif), according to the manufacturer’s instructions. The anti-NF-κ B family primary antibodies recog-
nize an epitope that is accessible only when NF-κ B is activated and bound to its target DNA.
Statistical Analysis. Mean, standard deviation (SD), standard error of the mean (SEM) and statistical 
tests were calculated using GraphPad Prism (GraphPad Software, San Diego, CA). For the ELISA exper-
iments, the Mann Whitney test was used to compare 2 groups of data, P value of < 0.05 was considered 
significant (*p < 0.05 **p < 0.001).
For the DNA binding experiments, statistical analysis was carried out using a 1-way analysis of vari-
ance (ANOVA) with Dunnett’s multiple comparison post-test (*p < 0.05; **p < 0.01, ***p < 0.001).
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